AZ unveils monster US$80B target
Overnight AstraZeneca unveiled its "bold ambition" to deliver US$80 billion in total revenue by the end of decade with the launch of 20 new medicines.
To see the whole article, log in or create an account.
Sat, 10 Oct 2026
Connecting you with your industry every day